In the most recent quarter (H1), Mesoblast reported EPS of $-0.03, beating estimates of $-0.20 by 0.85%. Revenue came in at $51.34M, exceeding the estimate of $17.57M by 1.92%.
Mesoblast has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Mesoblast has averaged an EPS surprise of 0.51% and a revenue surprise of 3.09%.
Analyze the earnings history of Mesoblast using advanced sorting and filters.
The chart below shows Mesoblast's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Mesoblast's reported revenue compared to analyst estimates over recent quarters.
Mesoblast (MESO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 26, 2026 for H1.
Mesoblast (MESO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 26, 2026 for H1 and the Actual EPS was $-0.03, which beat the estimate of $-0.20.
Mesoblast (MESO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 26, 2026 for H1 and the Actual Revenue was $51.34M, which beat the estimate of $17.57M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| H1 | 2026-02-26 | $-0.03 | $-0.20 | 84.5 % |
| FY | 2025-08-28 | $-0.09 | $-0.71 | 88.0 % |
| Q4 | 2023-08-30 | $-0.28 | $-0.30 | 6.67 % |
| Q3 | 2023-05-25 | $-0.25 | $-0.34 | 25.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| H1 | 2026-02-26 | $51.34M | $17.57M | 192.2 % |
| FY | 2025-08-28 | $17.20M | $42.87M | -59.9 % |
| Q4 | 2023-08-30 | $2.14M | $2.37M | -974.7 % |
| Q3 | 2023-05-25 | $1.94M | $2.14M | -9.39 % |